Core Laboratories N.V. (CLB) P/E Ratio History
Deep ValueTrading at 18.7x · 10th percentile of 5-year range · Significant discount to historical valuation · Data 1996–2026
Loading P/E history...
P/E Ratio Analysis
As of June 16, 2026, Core Laboratories N.V. (CLB) trades at a price-to-earnings ratio of 18.7x, with a stock price of $12.72 and trailing twelve-month earnings per share of $0.68.
The current P/E is 56% below its 5-year average of 42.6x. Over the past five years, CLB's P/E has ranged from a low of 18.3x to a high of 151.8x, placing the current valuation at the 10th percentile of its historical range.
Compared to the Energy sector median P/E of 16.4x, CLB is roughly in line with its sector peers. The sector includes 173 companies with P/E ratios ranging from 1.8x to 172.4x.
Relative to the broader market, CLB trades at a notable discount to the S&P 500 median P/E of 25.0x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CLB DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CLB Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CLB P/E vs Peers
Seismic and Reservoir Evaluation peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 31.5 | -Best | -52% | |
| $2B | 1947.4 | -Best | +101% | |
| $2B | 45.9 | -Best | -65% | |
| $2B | 92.4 | -Best | -33% | |
| $81B | 22.9 | -Best | -24% | |
| $32B | 25.5 | -Best | -47% | |
| $62B | 24.0 | -Best | -13% | |
| $141M | 6.2Lowest | -Best | +239%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CLB Historical P/E Data (1996–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $16.79 | $0.65 | 25.8x | -45% |
| FY2025 Q4 | Dec 31 2025 | $16.03 | $0.67 | 24.0x | -48% |
| FY2025 Q3 | - | $12.36 | $0.68 | 18.3x | -61% |
| FY2025 Q2 | Jun 30 2025 | $11.52 | $0.63 | 18.4x | -61% |
| FY2025 Q1 | Mar 31 2025 | $14.99 | $0.60 | 25.1x | -46% |
| FY2024 Q4 | - | $17.31 | $0.67 | 25.9x | -44% |
| FY2024 Q3 | Sep 30 2024 | $18.53 | $0.56 | 33.2x | -29% |
| FY2024 Q2 | Jun 30 2024 | $20.29 | $0.50 | 40.8x | -12% |
| FY2024 Q1 | Mar 31 2024 | $17.08 | $0.79 | 21.7x | -53% |
| FY2023 Q4 | Dec 31 2023 | $17.66 | $0.77 | 22.9x | -51% |
| FY2023 Q3 | Sep 30 2023 | $24.01 | $0.86 | 27.9x | -40% |
| FY2023 Q2 | Jun 30 2023 | $23.25 | $0.83 | 28.0x | -40% |
| FY2023 Q1 | Mar 31 2023 | $22.05 | $0.50 | 44.1x | -5% |
| FY2022 Q4 | Dec 31 2022 | $20.27 | $0.41 | 49.4x | +6% |
| FY2022 Q3 | Sep 30 2022 | $13.48 | $0.33 | 41.1x | -12% |
| FY2022 Q2 | - | $19.81 | $0.19 | 105.2x | +126% |
| FY2022 Q1 | - | $31.63 | $0.21 | 151.8x | +226% |
| FY2021 Q4 | Dec 31 2021 | $22.31 | $0.43 | 52.1x | +12% |
| FY2021 Q3 | - | $27.75 | $0.67 | 41.4x | -11% |
| FY2021 Q2 | Jun 30 2021 | $38.95 | $0.72 | 54.1x | +16% |
| FY2021 Q1 | Mar 31 2021 | $28.79 | $0.42 | 68.5x | +47% |
| FY2019 Q4 | - | $37.67 | $2.28 | 16.5x | -65% |
| FY2019 Q3 | Sep 30 2019 | $46.62 | $2.25 | 20.7x | -56% |
| FY2019 Q2 | Jun 30 2019 | $52.28 | $2.22 | 23.5x | -49% |
| FY2019 Q1 | Mar 31 2019 | $68.93 | $2.17 | 31.8x | -32% |
| FY2018 Q4 | Dec 31 2018 | $59.66 | $1.79 | 33.3x | -28% |
| FY2018 Q3 | Sep 30 2018 | $115.83 | $2.08 | 55.7x | +20% |
| FY2018 Q2 | Jun 30 2018 | $126.21 | $2.06 | 61.3x | +32% |
| FY2018 Q1 | Mar 31 2018 | $108.22 | $2.01 | 53.8x | +16% |
| FY2017 Q4 | Dec 31 2017 | $109.55 | $1.88 | 58.3x | +25% |
| FY2017 Q3 | Sep 30 2017 | $98.70 | $1.74 | 56.7x | +22% |
| FY2017 Q2 | Jun 30 2017 | $101.27 | $1.64 | 61.8x | +33% |
| FY2017 Q1 | Mar 31 2017 | $115.52 | $1.51 | 76.5x | +64% |
| FY2016 Q4 | Dec 31 2016 | $120.04 | $1.46 | 82.2x | +76% |
| FY2016 Q3 | Sep 30 2016 | $112.33 | $1.47 | 76.4x | +64% |
| FY2016 Q2 | - | $123.89 | $1.87 | 66.3x | +42% |
| FY2016 Q1 | - | $112.41 | $2.30 | 48.9x | +5% |
| FY2015 Q4 | - | $108.74 | $2.67 | 40.7x | -13% |
| FY2015 Q3 | Sep 30 2015 | $99.80 | $3.82 | 26.1x | -44% |
| FY2015 Q2 | - | $114.04 | $4.54 | 25.1x | -46% |
| FY2015 Q1 | - | $104.49 | $5.15 | 20.3x | -56% |
| FY2014 Q4 | Dec 31 2014 | $120.34 | $5.78 | 20.8x | -55% |
| FY2014 Q3 | - | $146.35 | $5.69 | 25.7x | -45% |
| FY2014 Q2 | Jun 30 2014 | $167.06 | $5.54 | 30.2x | -35% |
| FY2014 Q1 | Mar 31 2014 | $198.44 | $5.41 | 36.7x | -21% |
| FY2013 Q4 | - | $190.95 | $5.28 | 36.2x | -22% |
| FY2013 Q3 | Sep 30 2013 | $169.21 | $5.03 | 33.6x | -28% |
| FY2013 Q2 | Jun 30 2013 | $151.66 | $4.82 | 31.5x | -32% |
| FY2013 Q1 | Mar 31 2013 | $137.92 | $4.64 | 29.7x | -36% |
| FY2012 Q4 | Dec 31 2012 | $109.31 | $4.55 | 24.0x | -48% |
| FY2012 Q3 | Sep 30 2012 | $121.48 | $4.49 | 27.1x | -42% |
| FY2012 Q2 | Jun 30 2012 | $115.90 | $4.28 | 27.1x | -42% |
| FY2012 Q1 | Mar 31 2012 | $131.57 | $4.00 | 32.9x | -29% |
| FY2011 Q4 | Dec 31 2011 | $113.95 | $3.81 | 29.9x | -36% |
| FY2011 Q3 | Sep 30 2011 | $89.83 | $0.89 | 100.9x | +117% |
| FY2011 Q2 | - | $111.54 | $0.75 | 148.7x | +219% |
| FY2011 Q1 | - | $102.17 | $0.63 | 162.2x | +248% |
| FY2010 Q4 | Dec 31 2010 | $89.05 | $0.38 | 234.3x | +403% |
| FY2010 Q3 | - | $88.04 | $2.70 | 32.6x | -30% |
| FY2010 Q2 | Jun 30 2010 | $73.81 | $2.58 | 28.6x | -39% |
| FY2010 Q1 | Mar 31 2010 | $65.40 | $2.51 | 26.1x | -44% |
| FY2009 Q4 | - | $59.06 | $2.45 | 24.1x | -48% |
| FY2009 Q3 | Oct 19 2009 | $54.52 | $2.70 | 20.2x | -57% |
| FY2009 Q2 | - | $43.57 | $2.85 | 15.3x | -67% |
| FY2009 Q1 | - | $36.58 | $2.87 | 12.7x | -73% |
| FY2008 Q4 | Dec 31 2008 | $29.93 | $2.80 | 10.7x | -77% |
| FY2008 Q3 | - | $50.66 | $2.76 | 18.4x | -61% |
| FY2008 Q2 | Jun 30 2008 | $71.18 | $2.59 | 27.5x | -41% |
| FY2008 Q1 | Mar 31 2008 | $59.65 | $2.52 | 23.7x | -49% |
| FY2007 Q4 | Dec 31 2007 | $62.36 | $2.48 | 25.1x | -46% |
| FY2007 Q3 | Sep 30 2007 | $63.70 | $2.25 | 28.3x | -39% |
| FY2007 Q2 | Jun 30 2007 | $50.85 | $2.02 | 25.2x | -46% |
| FY2007 Q1 | Mar 31 2007 | $41.92 | $1.78 | 23.6x | -49% |
| FY2006 Q4 | Dec 31 2006 | $40.50 | $1.55 | 26.1x | -44% |
| FY2006 Q3 | Sep 30 2006 | $31.90 | $1.14 | 27.9x | -40% |
| FY2006 Q2 | Jun 30 2006 | $30.52 | $0.86 | 35.3x | -24% |
| FY2006 Q1 | Mar 31 2006 | $23.78 | $0.70 | 33.8x | -27% |
| FY2005 Q4 | Dec 31 2005 | $18.68 | $0.57 | 32.6x | -30% |
| FY2005 Q3 | Sep 30 2005 | $16.13 | $0.65 | 24.8x | -47% |
| FY2005 Q2 | - | $13.41 | $0.64 | 21.0x | -55% |
| FY2005 Q1 | - | $12.84 | $0.49 | 25.9x | -44% |
| FY2004 Q4 | Dec 31 2004 | $11.68 | $0.23 | 51.9x | +11% |
| FY2004 Q3 | - | $12.30 | $0.18 | 66.5x | +43% |
| FY2004 Q2 | Jun 30 2004 | $11.50 | $0.15 | 74.2x | +59% |
| FY2004 Q1 | Mar 31 2004 | $10.60 | $0.18 | 57.3x | +23% |
| FY2003 Q4 | Dec 31 2003 | $8.35 | $0.32 | 26.5x | -43% |
| FY2003 Q3 | - | $7.03 | $0.13 | 53.3x | +14% |
| FY2003 Q2 | Jun 30 2003 | $5.40 | $0.11 | 48.7x | +5% |
| FY2003 Q1 | Mar 31 2003 | $5.20 | $0.09 | 57.2x | +23% |
| FY2002 Q1 | Mar 31 2002 | $7.38 | $0.03 | 295.2x | +534% |
| FY2001 Q4 | Dec 31 2001 | $7.01 | $0.32 | 22.3x | -52% |
| FY2001 Q3 | Sep 30 2001 | $6.43 | $0.43 | 14.8x | -68% |
| FY2001 Q2 | Jun 30 2001 | $9.38 | $0.38 | 24.4x | -48% |
| FY2001 Q1 | Mar 31 2001 | $9.39 | $0.32 | 29.4x | -37% |
| FY2000 Q4 | Dec 31 2000 | $13.66 | $0.27 | 50.8x | +9% |
| FY2000 Q3 | Sep 30 2000 | $12.28 | $0.23 | 54.1x | +16% |
| FY2000 Q2 | Jun 30 2000 | $14.50 | $0.22 | 66.8x | +43% |
| FY2000 Q1 | Mar 31 2000 | $14.53 | $0.20 | 73.7x | +58% |
| FY1999 Q4 | Dec 31 1999 | $10.00 | $0.06 | 175.1x | +276% |
| FY1999 Q3 | - | $9.38 | $0.07 | 131.7x | +183% |
| FY1999 Q2 | Jun 30 1999 | $7.00 | $0.13 | 53.4x | +15% |
| FY1999 Q1 | Mar 31 1999 | $8.81 | $0.15 | 60.3x | +29% |
| FY1998 Q4 | - | $9.56 | $0.32 | 30.2x | -35% |
| FY1998 Q3 | Sep 30 1998 | $8.63 | $0.38 | 22.7x | -51% |
| FY1998 Q2 | - | $10.81 | $0.34 | 31.8x | -32% |
| FY1998 Q1 | - | $12.19 | $0.36 | 33.4x | -28% |
| FY1997 Q4 | Dec 31 1997 | $9.03 | $0.34 | 26.6x | -43% |
| FY1997 Q3 | - | $8.75 | $0.27 | 32.5x | -30% |
| FY1997 Q2 | Jun 30 1997 | $6.50 | $0.22 | 29.7x | -36% |
| FY1997 Q1 | Mar 31 1997 | $4.44 | $0.19 | 23.5x | -50% |
| FY1996 Q4 | - | $4.19 | $0.18 | 22.8x | -51% |
| FY1996 Q3 | Sep 30 1996 | $3.94 | $0.19 | 20.4x | -56% |
Average P/E for displayed period: 46.6x
What if you invested $1,000 in CLB back in 1996?
Total return with dividends reinvested · 30+ years of data
Calculate ReturnsHow much would $100/month in CLB be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs CLB Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCLB vs XOM — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Exxon Mobil Corporation.
Compare NowCLB — Frequently Asked Questions
Quick answers to the most common questions about buying CLB stock.
What is CLB's P/E ratio?
Core Laboratories N.V. (CLB) trailing twelve-month P/E ratio is 18.7x, based on TTM diluted EPS of $0.68. The 5-year average P/E is 42.6x and the historical range spans 18.3x to 151.8x.
Is CLB stock overvalued or undervalued?
CLB trades at 18.7x P/E, below its 5-year average of 42.6x. At the 10th percentile of its historical range (18.3x–151.8x), the stock is priced at a discount to its own history.
Is CLB stock expensive?
No, CLB is not expensive on a historical basis. The current P/E of 18.7x is below the 5-year average of 42.6x and sits at the 10th percentile of its valuation range.
What is CLB's historical P/E range?
Over the past 5 years, CLB's P/E ratio has ranged from 18.3x to 151.8x, with a median of 33.2x and an average of 42.6x. The current P/E of 18.7x places the stock at the 10th percentile of this range. Full historical data spans 1996–2026.
How does CLB's P/E compare to the S&P 500?
CLB trades at 18.7x P/E versus the S&P 500 median of 25.0x. The 25% discount to the market suggests lower growth expectations or perceived higher risk.
How does CLB's valuation compare to Energy peers?
Core Laboratories N.V. P/E of 18.7x compares to the Energy sector median of 16.4x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CLB's PEG ratio?
CLB PEG ratio is N/A, based on a P/E of 18.7x and EPS growth of 3.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CLB's earnings yield?
CLB earnings yield is 5.35%, the inverse of its 18.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.